The 1st choice for food, pharma, and feed ingredients

Discover Bioseutica®: Innovators in Natural Proteins and Enzymes for Food, Pharma, and Feed Industries

Zoom Aa-aA+

We are a leading ingredients company, and our natural proteins and enzymes are the first choice across the food, pharma, and feed industries. With a tradition of innovation spanning nearly 75 years as an enzyme manufacturing company, we aim to become the global market leader in the responsible development of proteins with our proprietary solvent-free processes. We are committed to R&D, knowing that scientific developments have led to the definition of our innovative portfolio of products, patents, and proprietary technologies. At Bioseutica®, we focus on the global supply of non-GMO ultrapure bioactive proteins and functional foods, extracting nature’s best from eggs and the pancreas. Our egg-derived proteins are highly valued across broad industries that take inspiration from their roles in nature. Lysozyme, Avidin, and Ovotransferrin (conalbumin) possess potent natural antimicrobial properties, utilized extensively across food processing, food safety, animal health, nutrition, hygiene, and pharmaceutical industries. Bioseutica® is a globally recognized enzyme company for food, nutrition, health supplements, animal healthcare, and pharmaceuticals. Leveraging our expertise as global leaders in Lyszoyme production, we have developed specialty formulations, including the natural nootropic NA2R®, LYSOVIN™ for precision fermentation in winemaking, LYSOLAC® for dairy products, and the livestock immunity-boosting Entegard® range. 


Bioseutica® Group

Bioseutica® Group comprises Neova Technologies Inc., Fordras SA, and Healiva SA. Neova Technologies Inc., based in Abbotsford, Canada, draws on forty years of expertise in bioseparation and protein fractionation, having built its reputation on quality and customer service. Fordras SA, based in Lugano, Switzerland, has served the pharmaceutical and food industries since 1983.  Healiva SA, also based in Lugano, Switzerland, was launched in 2020. An innovative patient-centric biotech company that delivers affordable precision therapeutics to improve people's quality of life. Using a multi-pronged approach, Healiva SA combines digital health, enzyme technology, and cell therapy to address unmet patient needs in regenerative wound care.

Neova Technologies Fordras Healiva


Beyond the Egg: High-Quality Pancreatic Digestive Enzymes

Beyond the egg, we also extract pancreatic digestive enzymes, including Trypsin, chymotrypsin (protease), Aquatryp® (A non-mammalian, non-microbial enzyme mixture), and Phospholipase A2 (hydrolase). These protease and protease blends have extensive applications in food, nutrition (infant and follow-on formulae), diagnostics, dietary supplements, food processing, pharmaceutical, and medical research applications requiring the faithful mimicking of natural digestive processes.  Our manufacturing processes are built on these high-end, cutting-edge proprietary technologies, allowing us to produce ingredients of the highest quality in our facilities across Canada and Europe.  Our international reputation is built on our quality and service reliability.


Leading Enzyme Manufacturer for the USA and China markets: Excellence in Muramidase, Hydrolase, and Protease Solutions

As a premier enzyme manufacturer for the USA and China markets, Bioseutica® stands at the forefront of biotechnological innovation, delivering high-quality muramidase, hydrolase, and protease solutions to global customers. Our cutting-edge facilities and commitment to excellence ensure that each product we manufacture meets stringent quality standards, making us a trusted partner in the enzyme industry. With a robust focus on sustainability and efficiency, our enzymatic solutions cater to various applications, helping industries enhance performance and achieve their environmental goals. Whether in the USA, China, or any other part of the world, rely on Bioseutica® for superior enzyme manufacturing services tailored to your needs.

About us Our Products Read our Blog


Bioseutica® goes circular! Opportunities for West III program grant

Bioseutica® COFINANCED BY EU Initiative

Bioseutica® is leading a project to develop a novel lysozyme product (bioactive protein) for the feed industry through the extraction of lysozyme from a residual feed stream. This Technical Lysozyme will be produced within a circular stream of valuable protein sources for the feed industry. The initiative receives financial support from the European Union through the EFRO program Opportunities for West III. This program focuses on the transition to a fully circular and climate-neutral economy, with an important milestone at the end of the program period in 2030.

EFRO Website



Bioseutica® is in the advanced r&d development of amcipatricin by inhalation for treatment and/or prevention of severe fungal infections in cystic fibrosis and/or immunocompromised patients (patent pending). Bioseutica® is looking for development and commercial partners.


Fungal diseases are a public health issue: opportunistic infections (e.g., cryptococcosis and aspergillosis), hospital-associated infections (e.g., candidemia), and community-acquired infections pose a critical threat to public health1. Globally, over 300 million people are afflicted with a severe fungal infection, and 25 million are at high risk of dying or losing their sight2. AMCIPATRICIN diascorbate (code SPK-843) is a new semi-synthetic, water-soluble polyene antibiotic with potent broad-spectrum antifungal activity, particularly against Candida spp., Cryptococcus sp., and Aspergillus spp.

Read More


100 years of Lysozyme

2022 marked 100 years since news of Lysozyme’s discovery reached the Royal Society. Let us take you on the journey of this 100-year story:

100 years of Lysozyme - Episode III

Episode III Instalment 3

Lysozyme leads the way for DeepMind’s AlphaFold

Lysozyme contributed directly to our understanding of the structure-function relationship of proteins. It was the first solved structure that established the concept that the 3D shape of a  protein[...]

100 years of Lysozyme - Episode I Instalment 1

Episode I Instalment 1

A beginning for Lysozyme

Bioseutica® group has been producing lysozyme from hen egg-white since the 1950s, a history spanning nearly 75 years. But lysozyme’s story doesn’t begin with us. For that, we must look back to the earliest human use of egg-white[...]

100 years of Lysozyme - Episode I Instalment 2

Episode I Instalment 2

Thus ended the collection of tears

The second installment of our 100 Years of Lysozyme series is live. This week, we discover how the abundance of Lysozyme in eggs was first discovered (hint: it wasn’t in the supermarket)[...]

100 years of Lysozyme - Episode I Instalment 3

Episode I Instalment 3

Not a great lecturer

Fleming’s shyness, his being “not a great lecturer” as acknowledged by Allison, may in part account for the poor reception received at the first reading of the initial paper describing lysozyme[...]

100 years of Lysozyme - Episode I Instalment 4

Episode I Instalment 4

Try £ 3

From 3p for tears to £3 for Picassos; in this installment, we uncover how Alexander Fleming’s eye and contributions had an immeasurable impact on medicine and science in the 20th century[...]

100 years of Lysozyme - Episode II Instalment 1

Episode II Instalment 1

A Tradition of Innovation

The aftermath of the war has left Italy economically devastated like the rest of the European countries. In Milan, another Ferrari began production, but this time with Penicillin.[...]

100 years of Lysozyme - Episode II Instalment 2

Episode II Instalment 2

A Tradition of Innovation 2

The death of their first trial patient through the insufficient supply of Penicillin drove Florey, Chain, and their research assistant, Heatley, forward with inspired momentum.[...]

100 years of Lysozyme - Episode II Instalment 3

Episode II Instalment 3

A Tradition of Innovation 3

24th May 1947 saw the establishment of SPA (Società Prodotti Antibiotici) by Pharmacologist Dr. Rodolfo Ferrari and microbiologist Carlo Callerio. Now Italy had its own, domestic Penicillin[...]

100 years of Lysozyme - Episode III Instalment 1

Episode III Instalment 1

More than an antimicrobial

To most of us, if at least those reading, I hope Lysozyme is best known as a potent, natural antimicrobial. This is its primary purpose for the hen's egg, making[...]

100 years of Lysozyme - Episode III Instalment 2

Episode III Instalment 2

Finding the structure

Sir. William Bragg and Sir. Lawrence Bragg won the Nobel Prize in 1915 for their work on analyzing crystal structures using X-rays. This award is notable not only as it was the first and [...]




About Bioseutica®


Discover Bioseutica® a leading ingredients company whose natural proteins and enzymes are the first choice across food, pharma, and feed industries. With a tradition of innovation spanning nearly 75 years, we aim to become the global [...] 


Bioseutica® Food Ingredients


An overview of our natural food ingredients for clean-label products. Bioseutica®'s enzymes and proteins are solvent and GMO-free to ensure the highest quality standard[...] 


Bioseutica® NA2R®


NA2R® is a clinically proven natural ingredient for the novel food/nootropics industry. Its daily consumption leads to increased brain serotonin levels, exerting physiologically beneficial effects on the brain[...] 



DCAT The Drug, Chemical & Associated Technologies Association

Bioseutica® is a DCAT, The Drug, Chemical & Associated Technologies Association member, which powers relationships and industry knowledge for pharmaceutical development and manufacturing companies. DCAT is a 501(c)6, not-for-profit, member-supported, global business development association whose unique membership model integrates innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. Since 1890, DCAT has provided a life-long collegial community for industry representatives for over 125 years. DCAT is committed to providing programs, events, and services that help members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and issues impacting pharmaceutical development and manufacturing.


Each of Bioseutica®'s affiliates holds certifications attesting to our commitment to the highest possible quality standards.

  • HACCP certification for our plants in North America
  • Lysozyme Kosher certification
  • Lysozyme Halal certification
  • GMP certificates for Lysozyme plants in the EU 
  • Lysozyme is affirmed as GRAS by the US Fed. Register of rules and regulations since 1998
  • GDP by Swissmedic
  • FSSC 22000


Latest news

EFSA scientific opinion on Lysozyme from hen’s egg
EFSA opinion on Bioseutica's application for Lysozyme from hens’ eggs

EFSA : Lysozyme does not give rise to safety concerns

The food enzyme lysozyme (peptidoglycanN-acetylmuramoylhydrolase; EC is produced from hens eggs by Bioseutica® B.V.  It is intended to be used in brewing processes, milk processing for cheese production as well as wine production. The dietary exposure to the food enzyme–total organic solids (TOS) was estimated to be up to 4.9 mg TOS/kg body weight per day.

Bioseutica® Ovotransferrin
Looking for a lactoferrin substitute? Try Ovotransferrin - with similar molecular properties and thermal stability to bovine and human lactoferrin.

Enhancing Protein Product Quality: Ovotransferrin as a Superior Substitute for Lactoferrin

To improve your protein products' processing quality and biological activities? Try using Ovotransferrin as a lactoferrin substitute. Ovotransferrin (OVT) is a protein that has a high similarity to Bovine lactoferrin (BLF) and human lactoferrin (HLF) and may be used as a substitute for lactoferrin (LF) due to its limited production.